OWC Pharmaceutical Research Corp. (OWCP) Research

OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.

Market snapshot

Symbol
OWCP
Price
$0.00
Day change
0.00%
Market cap
$5.0K
P/E ratio
-0.00x
52-week range
0.00001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • ARYx Therapeutics, Inc. (ARYX)
  • Abattis Bioceuticals Corp. (ATTBF)
  • Biome Grow Inc. (BIOIF)
  • Cannabis Global, Inc. (CBGL)
  • Psykey, Inc. (CEOS)
  • Hero Technologies Inc. (HENC)
  • Instadose Pharma Corp. (INSD)
  • Isodiol International Inc. (ISOLF)

Recent insider activity

  • Sunbeam Management, LLC — trade (0 shares) on 2020-03-23
  • Sunbeam Management, LLC — trade (43675 shares) on 2020-03-23
  • BARUCH YEHUDA — trade (0 shares) on 2014-12-22
  • BARUCH YEHUDA — trade (7000000 shares) on 2016-12-15
  • De-Saban Shmuel — trade (0 shares) on 2016-12-31

Open OWC Pharmaceutical Research Corp. (OWCP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.